Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 56.10
ILS 5049.08ILS 56.10
ILS 672.86
60 tablet
Free AirMail shipping Hot
ILS 59.84
ILS 3590.40ILS 59.84
ILS 224.22
30 tablet
Free AirMail shipping Hot
ILS 63.58
ILS 1907.31ILS 63.58
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 67.32
ILS 6058.94ILS 67.32
ILS 336.24
60 tablet
Free AirMail shipping Hot
ILS 69.19
ILS 4151.43ILS 69.19
ILS 112.02
30 tablet
Free AirMail shipping Hot
ILS 71.06
ILS 2131.73ILS 71.06
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 80.41
ILS 7237.10ILS 80.41
ILS 336.24
60 tablet
Free AirMail shipping Hot
ILS 82.28
ILS 4936.88ILS 82.28
ILS 112.02
30 tablet
Free AirMail shipping Hot
ILS 84.15
ILS 2524.45ILS 84.15
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.